CME Live Webinar

From Hypertension to Cardiovascular Disease and the role of Artificial Intelligence (AI)

19 June 2026
From 14.00 to 15.00 CEST

On demand session Final Programme
scroll-down-icon
ON DEMAND SESSION

Click to watch the Pre-webinar interview

DOWNLOAD INFOGRAPHIC

Back to Main page

Overview

High blood pressure (BP)/hypertension is associated with the strongest evidence for causation of CVD [Fuchs, 2020]. Indeed, trials over time have demonstrated the potential CVD benefits associated with BP-lowering treatments at lower and lower pre-treatment BP measurements and at any stage of hypertension duration [McCarthy, 2024; Pfeffer, 2016; Ling 2024]. Recent artificial intelligence (AI) advances in CV medicine and care offer potential enhancements in diagnosis, accelerate making clinical decisions, treatment, clinical outcomes, remote patient monitoring, patient phenotyping and assessing the risk of complications [Elias, 2024; Belenkov, 2025] as well as enhancing risk prediction [Teshale, 2024; Tremamunno, 2025; Chaparala, 2025; Gonzalez, 2024]. To-date, AI innovations span automating measurements, enhancing image quality/tomographic image analysis as well as wearable devices, echocardiography, angiography and genetics [Ose, 2024] at a greater accuracy not previously achieved. AI shows great promise in enhancing CVD care through more accurate and efficient approaches [Bota, 2024]. However, the unique characteristics offered by AI require rigorous validation in terms of training, real-world efficacy, equity concerns and long-term reliability and future efforts should focus on the impact of AI technologies on patient outcomes and ethical challenges [Guha, 2025; Shaikh, 2025].

Learning Objectives

At the end of the activity, learners should be able to:

  • • Appreciate the factors to consider when treating hypertension and the impact they have on the development of CVD
  • • Be familiar with the latest understanding for predicting the development of CVD from hypertension
  • • Understand the role of AI in the risk prediction, detection and management of CVD and its ethical considerations and implications

Target Audience

Clinicians (including cardiologists, internists, and general practitioners), nurse practitioners and other HCPs who diagnose and manage patients with CVD and hypertension.

Language

English with simultaneous translation into Russian and Chinese

Continuing Medical Education

The From Hypertension to Cardiovascular Disease and the role of Artificial Intelligence (AI) – Virtual, Italy, 19/06/2026 – 19/06/2026 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

uems-eaccme-logo

The content of From Hypertension to Cardiovascular Disease and the role of Artificial Intelligence (AI) has been certified by the CPD Certification Service as conforming to continuing professional development principles.

From Hypertension to Cardiovascular Disease and the role of Artificial Intelligence (AI)

19 June 2026

Faculty

Stefano Taddei

Stefano Taddei

Professor of Internal Medicine
Director of the Hypertension Unit
Department of Clinical and Experimental Medicine
University of Pisa
Pisa, Italy
Biography
Gianluigi Savarese

Gianluigi Savarese

Professor of Cardiology
Head of the Center for Heart Failure and Arrhythmia
Department of Clinical Science and Education
Karolinska Institutet, Stockholm
Senior Consultant for Heart failure
Southern Hospital, Stockholm
President Elect of the Heart Failure Association of the European Society of Cardiology
Stockholm, Sweden
Biography
Rhian M. Touyz

Rhian M. Touyz

Executive Director and Chief Scientific Officer
Research Institute of the McGill University Health Centre (RI-MUHC)
Montreal, Canada
Biography

International Committee

János Nemcsik

János Nemcsik

Vice-President, Hungarian Society of Hypertension
Associate Professor Department of Family Medicine
Semmelweis University
Budapest, Hungary
Biography
Konstantinos Tsioufis

Konstantinos Tsioufis

Professor of Cardiology
National and Kapodistrian University of Athens
Hippokration Hospital
Athens, Greece
Biography
Agostino Virdis

Agostino Virdis

President of the Italian Society of Hypertension (SIIA)
Professor of Internal Medicine, Department of Clinical and Experimental Medicine, University of Pisa
Director of the Geriatric Unit at the University Hospital of Pisa
Pisa, Italy
Biography

Partnerships & Endorsements

With the endorsement of the Società Italiana dell’Ipertensione Arteriosa (SIIA)

Final Programme

Download

Agenda

AGENDA

FUNDING

· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 60 countries and has published 482 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.

· Stefano Taddei ·

Stefano Taddei is Full Professor of Internal Medicine, currently working as Director of the Hypertension Unit at the Department of Clinical and Experimental Medicine of the University of Pisa, Italy. He is a fellow of the European Society of Cardiology, member of the European, International and American Society of Hypertension, the European Society of Clinical Investigation and the High Blood Pressure Council of the American Heart Association. Professor Taddei is an editorial board member for numerous international and national scientific journals, Hypertension, Journal of Hypertension, Journal of Cardiovascular Pharmacology, Blood Pressure and he is Deputy Editor of the European Heart Journal. His main research area is the neuro-humoral control of peripheral arterial circulation in essential and secondary hypertension, with particular emphasis on adrenergic mechanisms, non-adrenergic neurotransmitters, the circulating and vascular renin-angiotensin system and endothelial function. Professor Taddei has participated in numerous clinical studies and is the authors of more than 400 original papers, reviews editorials and book chapters in international scientific journals (H index: 74; Impact Factor: >3000).

· Gianluigi Savarese ·

Gianluigi Savarese is an Italian/Swedish cardiologist, currently Professor of Cardiology at Karolinska Institutet (Department of Clinical Science and Education) where he is head of the Center for Heart Failure and Arrhythmia. He is also Senior Consultant for Heart Failure at the Southern Hospital, Stockholm, Sweden. Over the last few years, he has published >430 articles on top peer reviewed journals. Major focus of his research is heart failure, with a particular interest in implementing use of guidelines recommended treatments, and phenotyping heart failure for improving clinical trial design. He is heavily involved in registry studies (Swedish Heart Failure Registry, ESC registries) and clinical trials, and he is expert in big data analysis. He is Secretary of the Heart Failure Association and he has served as board member and secretary of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. Among others, he is Deputy Editor of European Journal of Heart Failure, EHJ Valvular and Structural Disease, and EHJ-Open.

· Rhian M Touyz ·

Rhian M. Touyz, MBBCh, MScMed, PhD, is Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre (RI-MUHC), Canada Research Chair in Cardiovascular Medicine, and Dr Phil Gold Chair in Medicine at McGill University, Montreal. She is also British Heart Foundation Emeritus Chair and previously served for ten years as Director of the Institute of Cardiovascular and Medical Sciences and BHF Chair of Cardiovascular Medicine at the University of Glasgow, UK. An internationally renowned clinician-scientist, Dr Touyz’s research focuses on the molecular mechanisms of hypertension and cardiovascular disease, with particular interests in vascular signaling, redox biology, the renin–angiotensin–aldosterone system, cardiometabolic disease, vascular dementia, and translational cardiovascular medicine. She has published more than 690 peer-reviewed papers (h-index 161) and has been recognized as a Highly Cited Researcher in 2024 and 2025, placing her among the top 1% of scientists worldwide by citations. Dr Touyz is Editor-in-Chief of Hypertension and has played leading roles in major international scientific organizations, including serving as President of the International Society of Hypertension and Chair of the American Heart Association Hypertension Council. She co-chaired the 2024 European Society of Cardiology Hypertension Guidelines and has received numerous honors, including the American Heart Association Hypertension Research Excellence Award. A committed mentor and advocate for equity in academia, she founded the International Society of Hypertension’s Women in Hypertension Research Program.

· János Nemcsik ·

János Nemcsik was born in 08/02/1977., in Eger, Hungary. He graduated in medicine in 2001 and was awarded of Ph.D. degree in 2005, both in Semmelweis University, Budapest, Hungary. He is a specialist of internal medicine, family medicine, occupational medicine and hypertension care. He currently works as a general practitioner, he is also an associate professor at the Department of Family Medicine, Semmelweis University. Between 2017-2025, he was the secretary general of the Hungarian Society of Hypertension, now he is vice-president. He is member of the Executive Committee of Artery Society since 2021 and since 2025 he is the treasurer. He is the secretary of the Working Group of General Practitioners and Team-based Care of the European Society of Hypertension since 2025. He is involved in endothelial dysfunction, hypertension, vascular ageing and arterial stiffness research and he is also interested in psychosomatic connections. Three of his PhD students have already been graduated. Publications (without abstracts): 124, impact factors: 179.702, citations: 2025, independent citations: 1509, Hirsch index: 25

· Konstantinos Tsioufis ·

Professor Konstantinos Tsioufis is Director of 1st Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece (since 2021). He is also a Member of the Editorial Board and Reviewer in major Cardiology, Hypertension and Critical Care Journals.  Prof. Tsioufis’s areas of interest and expertise follow his Postgraduate Specialization in Hypertension and Interventional Cardiology (Hippokration Hospital) in 2000 and are the basis of his publications (>1000) and book chapters (>25). These also include preventive cardiology, hypercholesterolemia, diabetes mellitus, atherosclerotic disease, CAD, peripheral disease and CKD. He was also Principal Investigator in Phase III  intervention trials in the therapeutic areas of cardiovascular disease, atherosclerotic disease, CAD, CKD, peripheral arterial disease, renal denervation, heart failure, hypertension, myocardial infarction and contributed to the Good Clinical Practice 2024 (THE GLOBAL HEALTH NETWORK). Prof. Tsioufis is currently the Vice Dean of the School of Medicine, University of Athens (since 2024) and was the past President of the European Society of Hypertension (2017ꟷ2019) and the Hellenic Society of Cardiology (2016ꟷ2018). He was also a Member of the Task Force of 2018 ESC/ESH Hypertension guidelines, Member of the Task Force of 2021 ESC guidelines on CV prevention and Member of the Task Force of 2023 ESH hypertension guidelines.

· Agostino Virdis ·

Agostino Virdis is Full Professor of Internal Medicine at the Department of Clinical and Experimental Medicine of the University of Pisa, Director of the Geriatric Unit at the University Hospital of Pisa and Director of the Postgraduate School of Geriatrics at the University of Pisa (Italy).

He is the President of the Italian Society of Hypertension and Chair of the Working group “Small vessels” of the European Society of Hypertension.

His major research interest cover the local neuro-humoral control of microcirculation in primary and secondary forms of hypertension, as well as in other cardiovascular risk factors, either in animal and human models, with particular emphasis on the endothelium, the renin-angiotensin system, and vascular inflammation. Professor Virdis is the author of > 300 publications on peer reviewed journals with an h-index (“Scopus” and “Web of Science) of 71.

Join our Newsletter!

Stay in the know with our CME updates

Powered by  GDPR Cookie Compliance (opens in a new tab)
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.